Trial intelligence / Profile preview

Levothyroxine in Hemodialysis Patients

NCT03977207Recruiting

Sponsor
University of California, Irvine
Start
Jul 2020
Primary completion
Nov 2025
Modality
Small Molecules
Countries
1
01

Overview

Randomised, double-blind trial in hypothyroidism comparing Levothyroxine with Placebo (2 arms). Primary endpoints: Short Form 36 Physical Component Score at Week 24 and Coronary Artery Calcification Volume Score at Week 24. Started Jul 2020; status: recruiting.

02

Drugs

levothyroxine sodium
03

Conditions

hypothyroidism

Beyond the preview

Go deeper on NCT03977207.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03977207.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call